Media sera and Reagents- Cell culture Market Size was valued at USD 8.15 Billion in 2023. The Global Media sera and Reagents- Cell culture industry is projected to grow from USD 9.13 Billion in 2024 to USD 22.57 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 11.23% during the forecast period (2024 - 2032).
Cell culture is how cells grow under controlled conditions outside the natural environment. In cell culture, the conditions of each cell type are different, but the artificial environment consists of a medium or reagents that provide nutrients to the cell. Various media sera and reagents are necessary for cell culture.
The rise in demand for biotechnological and biopharmaceutical products, growing cases of increasing chronic diseases, and the growing demand for treating using cell culture methods will drive the market's growth. The higher investments in research and development in biotechnology will positively propel the market's growth. Many developments in the field of rDNA technology and pharmaceutical will stimulate the market's growth. The capital investment for a Cell culture facility is expensive, which may impede the growth of the market.
America occupies the largest market due to great investment in research and development in the biotech and pharma industries. The economic conditions for research and development are even higher. The growing awareness among people and the presence of key players in this region will be contributed to the growth of the market.
By March of 2024, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, Ampersand Capital Partners, had acquired Biologos LLC, which is a full-service manufacturer of custom and standard cell culture media, reagents, buffers, enzymes, and sera. This was founded in 1976 and is involved in manufacturing customized as well as standardized products that span various areas, including cell culture media, reagents and enzymes (for biotechnology purposes), salt/buffers (for chemical analysis), and sera with varied container fill packaging options. Located just outside Chicago, IL., Biologos operates from its new cGMP facility measuring 32k square feet. Ampersand’s expansion plans will be directed into areas such as product development/launching along with geographic diversity to support its global clients, including biopharmaceutical firms that explore tissues during their research, as well as gene therapy firms.
On May 3rd, 2023, the Captivate Bio news team released information on the recent developments related to the company’s diversification strategies. Captivate Bio has recently reached an agreement with NEST Scientific USA for exclusive distribution of selected products under the NEST brand name through its own sales network across North America. In addition to expanding its product line by more than 200 new items, Captivate Bio's portfolio will now include NEST-branded labware containing cell culture flasks of different volumes, tubes, pipets, dishes, plates, and bioprocessing tools. All these are available in various sizes, formats, or surface treatments.
There is also another update from Gemini Bioproducts LLC, which BelHealth Investment Partners LLC announced has opened a new manufacturing facility that will produce cell culture media such as sera buffers, among others used extensively in the gene therapy market. Gemini Bio’s newly constructed manufacturing plant at West Sacramento comprises a clean suite room spanning over 25000sq ft., cold storage, warehouse, and administration area and will increase its production capacity fourfold, enabling it to cope with the fast-growing demand from customers. Gemini Bio was recently awarded a $3.6 million-dollar federal government contract for the supply of essential items needed in response to the surge in demand for COVID-19 diagnostic tests. For example, VTM (Viral Transport Media) reagents are used as pickling solutions during the testing stages PBS (Phosphate Buffered Saline), or even simply Saline Solution itself supplied by Gemini Bio, all of which are produced at the new facility.
The global media sera and reagents- cell culture market is segmented on the basis of types, applications and end users.
On the basis of type, it is segmented into media, sera and reagents.
On the basis of media, it is further segmented into chemically defined media, serum-free media, protein free media, classical media and others.
On the basis of sera it is sub segmented into fetal bovine serum, new-born calf serum and others.
On the basis, of reagents it is further segmented into antibiotics, biological detergents, biological buffers, cell viability kits and reagents and others.
On the basis of applications it is segmented into cancer research, virology, toxicity testing, vaccine production, drug development and others.
And on the basis of end users, it is segmented into research laboratories, academic institutions, pathology labs and others.
Intended Audience
On the regional basis, the market is segmented into America, Europe, Asia Pacific and Middle East & Africa. America commands the largest market due to huge investment in research and development in biotech and pharma industries and its economic conditions for research and development. Rising awareness among the people and presence of many key players in this region have also contributed in the growth of the market.
Europe is the second largest market for media sera and reagents-cell culture market followed by Asia Pacific. Due to availability of funds for research and development activities and growing emphasis on research for treating diseases. Asia Pacific shows the fastest growth in this market due to an increase in prevalence of communicable diseases. Mostly, India and China are starting expenditure in research and development sector of healthcare domain.
Middle East & Africa has the lowest market for media, sera and reagents- cell culture market due to lack of technical knowledge and poor medical facilities.
Recent Development
April 2022: Captivate Bio, a globalscientific solutions provider, announced that expanded its portfolio of cell culture solutions and included new classical media along with custom media manufacturing services and its CET Cocktail, a kit of small molecule compounds for safe usage in research and regenerative medicine applications to greatly improve the human pluripotent stem cell (hPSC) workflow.
It is offering focuses on addressing supply gaps created by recent acquisitions of large biotech corporations, which have left researchers with increasingly limited options for reliable reagent manufacturing and supply. Captivate Bio's custom media, and procurement services will give industry partners additional options for sourcing high-quality cell culture reagents and defined media solutions and provide bulk supply and custom media formulations.
Some of the major players for the global media, sera and reagents- cell culture market are
| Report Attribute/Metric | Details |
| Â Â Market Size | Â Â USD 22.57 Billion |
| Â Â CAGR | Â Â 11.23% |
| Â Â Base Year | Â Â 2023 |
| Â Â Forecast Period | Â Â 2024-2032 |
| Â Â Historical Data | Â Â 2021 |
| Â Â Forecast Units | Â Â Value (USD Billion) |
| Â Â Report Coverage | Â Â Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Â Â Segments Covered | Â Â Type, Applications and End User |
| Â Â Geographies Covered | Â Â America, Europe, Asia Pacific and Middle East & Africa |
| Â Â Key Vendors | PAN biotech(Germany), Sigma Aldrich (US), Thermofisher Scientific (US), General electric company (US), Biowest (France), Merck KGaA (Germany), Lonza AG (Switzerland), Hi-media Laboratories (India), VWR International, PromoCell GmbH |
| Â Â Key Market Opportunities | Rise in demand for biotechnological and biopharmaceutical products |
| Â Â Key Market Drivers | Growing cases of increasing chronic diseases |
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
